First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors Meeting Abstract
| Authors: | Schram, A. M.; Kamath, S. D.; El-Khoueiry, A. B.; Borad, M. J.; Mody, K.; Mahipal, A.; Goyal, L.; Sahai, V.; Schmidt-Kittler, O.; Shen, J.; Jen, K. Y.; Deary, A.; Sherwin, C. A.; Padval, M.; Wolf, B. B.; Subbiah, V. |
| Abstract Title: | First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306267 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS4165 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4165 -- Source: Wos |
